Raymond James & Associates’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.73M | Buy |
394,006
+267,951
| +213% | +$1.86M | ﹤0.01% | 2029 |
|
|
2024
Q2 | $983K | Buy |
126,055
+21,645
| +21% | +$169K | ﹤0.01% | 2614 |
|
|
2024
Q1 | $741K | Buy |
104,410
+75,810
| +265% | +$538K | ﹤0.01% | 2781 |
|
|
2023
Q4 | $192K | Buy |
+28,600
| New | +$192K | ﹤0.01% | 3502 |
|
|
2022
Q4 | – | Sell |
-12,089
| Closed | -$56K | – | 3823 |
|
|
2022
Q3 | $56K | Sell |
12,089
-2,252
| -16% | -$10.4K | ﹤0.01% | 3649 |
|
|
2022
Q2 | $85K | Buy |
14,341
+535
| +4% | +$3.17K | ﹤0.01% | 3668 |
|
|
2022
Q1 | $267K | Buy |
13,806
+2,675
| +24% | +$51.7K | ﹤0.01% | 3457 |
|
|
2021
Q4 | $364K | Sell |
11,131
-35,930
| -76% | -$1.17M | ﹤0.01% | 3310 |
|
|
2021
Q3 | $1.93M | Sell |
47,061
-21,250
| -31% | -$871K | ﹤0.01% | 2130 |
|
|
2021
Q2 | $2.46M | Sell |
68,311
-2,681
| -4% | -$96.5K | ﹤0.01% | 1956 |
|
|
2021
Q1 | $2.77M | Buy |
70,992
+3,902
| +6% | +$152K | ﹤0.01% | 1801 |
|
|
2020
Q4 | $2.71M | Buy |
+67,090
| New | +$2.71M | ﹤0.01% | 1707 |
|